The article discusses a review of peer-reviewed observational studies or clinical trials which examined the link between cytochrome P450(CYP)2C19 variant genotypes and clinical outcomes in patients with coronary artery disease under clopidogrel treatment regimen. Study authors found that reduced function CYP2C19 genotypes may be associated with increased risk for stent thrombosis.